11-64116478-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_013280.5(FLRT1):c.211G>C(p.Gly71Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,708 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_013280.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLRT1 | NM_013280.5 | c.211G>C | p.Gly71Arg | missense_variant | Exon 3 of 3 | ENST00000682287.1 | NP_037412.2 | |
MACROD1 | NM_014067.4 | c.517+34761C>G | intron_variant | Intron 3 of 10 | ENST00000255681.7 | NP_054786.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLRT1 | ENST00000682287.1 | c.211G>C | p.Gly71Arg | missense_variant | Exon 3 of 3 | NM_013280.5 | ENSP00000507207.1 | |||
MACROD1 | ENST00000255681.7 | c.517+34761C>G | intron_variant | Intron 3 of 10 | 1 | NM_014067.4 | ENSP00000255681.6 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152120Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000559 AC: 14AN: 250562Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135496
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461588Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 727094
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152120Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.211G>C (p.G71R) alteration is located in exon 2 (coding exon 1) of the FLRT1 gene. This alteration results from a G to C substitution at nucleotide position 211, causing the glycine (G) at amino acid position 71 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Peripheral neuropathy Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has not been reported in the literature in individuals with FLRT1-related disease. This variant is present in population databases (rs777177875, ExAC 0.05%). This sequence change replaces glycine with arginine at codon 71 of the FLRT1 protein (p.Gly71Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at